Coherence Neuro
San Francisco, US · 5 known investors
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases. The company uses bioelectronic interfaces and AI to decode the body's neural signals and enable precise, adaptive therapeutic interventions.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
BW
Ben WoodingtonCo-founder & CEO
EJ
Elise JenkinsCo-founder & CTO
Investors · 5
In the news
- Coherence Neuro begins first clinical study for BCImassdevice.com · 2026
- Coherence Neuro Secures $10M to Advance Closed-Loop Neurotechnology for Cancer Treatment - News Centerg-medtech.com · 2025
- Why Coherence Neuro raises $10M ?startupsunion.com · 2025
- Coherence Neuro raises $10m for cancer treatment technology — Capital Briefcapitalbrief.com · 2025
- Coherence Neuro raises $10M seed round for BCI that aids in cancer treatmentmassdevice.com · 2025
- Startup in spotlight: Coherence Neuro raises $10M to launch closed-loop neuro system for cancer treatment — TFNtechfundingnews.com · 2025